Thymus removal and immune aging in people with Down syndrome
Official title: Natural History of Dysregulation and Aging of the Immune System in People With Trisomy 21 With and Without Thymectomy
Run by National Institutes of Health Clinical Center (CC) · NCT07416201 · Data updated 2026-11-12
This study will try to see if removing part of the thymus affects immune health over time in people aged 1 and older with Down syndrome, comparing those who had thymectomy to those who did not and to unaffected household relatives.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 1 Year to 120 Years |
| Sex | All |
| Enrollment | 700 (estimated) |
| Sponsor | National Institutes of Health Clinical Center (CC) NIH |
| Locations | 1 site (Bethesda, Maryland) |
| Status | Recruiting |
| Started | June 23, 2026 |
| Main results expected | May 1, 2040 |
| Study ends | November 1, 2040 |
| Registry record updated | October 29, 2026 |
| Trial ID | NCT07416201 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people aged 1 year or older with documented trisomy 21, including both those who have undergone partial thymectomy and those who have not, plus their unaffected household relatives for control comparisons.
✕Probably not a fit
People without Down syndrome, or those unable or unwilling to provide consent, attend yearly visits, or give biospecimens, are unlikely to receive direct benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a longitudinal observational cohort study enrolling people with trisomy 21 (Down syndrome), including individuals who have had partial thymectomy and those who have not, plus unaffected household relatives as controls. Participants have a baseline visit and yearly follow-up visits (at least annually for up to 15 years) with physical exams and collection of biospecimens such as blood and stool, and clinical data from routine care may also be used. The study aims to define immune signatures linked to infections, autoimmunity, lung disease progression, and malignancy, and to analyze how immunomodulatory treatments and prior thymectomy influence these outcomes. All visits occur at the NIH Clinical Center in Bethesda, Maryland, and extra visits can be scheduled as clinically indicated.
Why it matters
Potential benefit: If successful, this work could identify immune markers and long-term risks related to thymectomy in people with Down syndrome, helping guide monitoring and treatment decisions.
How similar studies have gone: Prior studies have documented immune abnormalities in Down syndrome and shown that thymectomy can alter immunity in other populations, but the long-term effects of thymectomy specifically in people with Down syndrome are not well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
* INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1\. Aged \>=1 year. 2\. Willingness to allow storage of specimens and data for future research. * Additional Inclusion Criteria for Affected Participants 1. Documented T21 based on chromosomal karyotype test. 2. Ability of participant or LAR to provide informed consent. * Additional Inclusion Criteria for Unaffected Relatives 1. Ability of participant to provide informed consent or, for individuals \<18 years of age, to provide informed assent as applicable. 2. Reside in the same household as the corresponding affected participant. EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participation in this study: 1\. Any condition that, in the judgment of the investigator, may put the participant at undue risk or make them unsuitable for participation in the study.
Where it's running
-
National Institutes of Health Clinical Center
Bethesda, Maryland, United States Recruiting
Study contacts
- Principal investigator: Luigi D Notarangelo, M.D. — National Institute of Allergy and Infectious Diseases (NIAID)
- Study coordinator: Luigi D Notarangelo, M.D.
- Email: luigi.notarangelo2@nih.gov
- Phone: (301) 761-7550
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Kinematic analysis of hand and arm movement in kids with Down syndrome, CP and healthy children
This study tests how well an instrumented Box and Block Test and motion tracking can measure upper-limb movement in healthy kids and those with pyramidal hemisyndrome or Down syndrome.
-
Sensory integration to help balance and movement in kids with Down syndrome
Aimed at seeing if adding sensory integration to physical therapy helps improve gross motor skills and balance in children with Down syndrome.
-
Collaboration for Down Syndrome Progress (CDP) in people with Down syndrome
A long-term study following people with Down syndrome of all ages to see how health and everyday life change over time.
-
JAK inhibitor treatment for Down syndrome in children and young adults
This study tests whether 6 months of tofacitinib can help improve safety and neurodevelopment in people with Down syndrome aged 6 to 22, compared with placebo.
-
Jump rope to improve navicular drop and foot posture in children with Down syndrome
This project will test whether adding jump-rope exercises to play activities helps improve foot posture in 4–15-year-old children with Down syndrome who have navicular drop.
-
Immune and breathing measurements in children with Down syndrome and pneumonia
This project tests whether blood immune markers and simple breathing measures are linked in children with Down syndrome who have acute pneumonia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.